Seattle’s Tasso Raises $100M Series B to Scale Self‑Administered Blood‑Collection Devices

Seattle startup Tasso raised $100 million in a Series B round to advance its self‑administered blood‑collection devices used for remote patient monitoring, decentralized clinical trials and mailed liquid or dried samples. The funding brings total capital to $131 million, building on prior grants and a $17 million raise in July 2020.

TTasso UUniversity of Washington